Ignite Creation Date:
2024-05-06 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 2:24 PM
Study NCT ID:
NCT05228015
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2022-01-07
Brief Title:
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors
Sponsor:
Ikena Oncology
Organization:
Ikena Oncology
Organization Data
Organization:
Ikena Oncology
Class:
INDUSTRY
Study ID:
IK930-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ikena Oncology
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None